BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21504504)

  • 1. Déjerine-Sottas syndrome with a silent nucleotide change of myelin protein zero gene.
    Taioli F; Cabrini I; Cavallaro T; Simonati A; Testi S; Fabrizi GM
    J Peripher Nerv Syst; 2011 Mar; 16(1):59-64. PubMed ID: 21504504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic clustering in MPZ mutations.
    Shy ME; Jáni A; Krajewski K; Grandis M; Lewis RA; Li J; Shy RR; Balsamo J; Lilien J; Garbern JY; Kamholz J
    Brain; 2004 Feb; 127(Pt 2):371-84. PubMed ID: 14711881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New mutation of the MPZ gene in a family with the Dejerine-Sottas disease phenotype.
    Floroskufi P; Panas M; Karadima G; Vassilopoulos D
    Muscle Nerve; 2007 May; 35(5):667-9. PubMed ID: 17143884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked phenotypic variation in a family with a new myelin protein zero mutation.
    Szabo A; Züchner S; Siska E; Mechler F; Molnar MJ
    Neuromuscul Disord; 2005 Nov; 15(11):760-3. PubMed ID: 16198109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe demyelinating hypertrophic polyneuropathy caused by a de novo frameshift mutation within the intracellular domain of myelin protein zero (MPZ/P0).
    Zschüntzsch J; Dibaj P; Pilgram S; Kötting J; Gerding WM; Neusch C
    J Neurol Sci; 2009 Jun; 281(1-2):113-5. PubMed ID: 19344920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel homozygous mutation of the myelin Po gene producing Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III).
    Ikegami T; Nicholson G; Ikeda H; Ishida A; Johnston H; Wise G; Ouvrier R; Hayasaka K
    Biochem Biophys Res Commun; 1996 May; 222(1):107-10. PubMed ID: 8630052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P0-deficient knockout mice as tools to understand pathomechanisms in Charcot-Marie-Tooth 1B and P0-related Déjérine-Sottas syndrome.
    Martini R
    Ann N Y Acad Sci; 1999 Sep; 883():273-80. PubMed ID: 10586252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and genetic description of a family with Charcot-Marie-Tooth disease type 1B from a transmembrane MPZ mutation.
    Eggers SD; Keswani SC; Melli G; Cornblath DR
    Muscle Nerve; 2004 Jun; 29(6):867-9. PubMed ID: 15170620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple de novo MPZ (P0) point mutations in a sporadic Dejerine-Sottas case.
    Warner LE; Shohat M; Shorer Z; Lupski JR
    Hum Mutat; 1997; 10(1):21-4. PubMed ID: 9222756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of I30T and I30M substitution in MPZ gene associated with Dejerine-Sottas syndrome type B (DSSB): A molecular modeling and dynamics.
    Agrahari A; George Priya Doss C
    J Theor Biol; 2015 Oct; 382():23-33. PubMed ID: 26135405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelin protein zero (MPZ) gene mutations in nonduplication type 1 Charcot-Marie-Tooth disease.
    Roa BB; Warner LE; Garcia CA; Russo D; Lovelace R; Chance PF; Lupski JR
    Hum Mutat; 1996; 7(1):36-45. PubMed ID: 8664899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin biopsies demonstrate MPZ splicing abnormalities in Charcot-Marie-Tooth neuropathy 1B.
    Sabet A; Li J; Ghandour K; Pu Q; Wu X; Kamholz J; Shy ME; Cambi F
    Neurology; 2006 Oct; 67(7):1141-6. PubMed ID: 17030746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dejerine-Sottas neuropathy with multiple nerve roots enlargement and hypomyelination associated with a missense mutation of the transmembrane domain of MPZ/P0.
    Simonati A; Fabrizi GM; Taioli F; Polo A; Cerini R; Rizzuto N
    J Neurol; 2002 Sep; 249(9):1298-302. PubMed ID: 12242557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early onset Charcot-Marie-Tooth type 1B disease caused by a novel Leu190fs mutation in the myelin protein zero gene.
    Kochański A; Kabzińska D; Drac H; Ryniewicz B; Rowińska-Marcińska K; Hausmanowa-Petrusewicz I
    Eur J Paediatr Neurol; 2004; 8(4):221-4. PubMed ID: 15261887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mutation of the myelin Po gene in hereditary motor and sensory neuropathy].
    Hayasaka K
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1444-6. PubMed ID: 8752425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelin protein zero gene mutations in Taiwanese patients with Charcot-Marie-Tooth disease type 1.
    Lee YC; Soong BW; Lin KP; Lee HY; Wu ZA; Kao KP
    J Neurol Sci; 2004 Apr; 219(1-2):95-100. PubMed ID: 15050444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of mutations in peripheral myelin protein-22, myelin protein zero, and connexin 32 in autosomal recessive Dejerine-Sottas syndrome.
    Stögbauer F; Young P; Wiebusch H; Timmerman V; Kuhlenbäumer G; Nelis E; Ringelstein EB; Kurlemann G; Assmann G; Van Broeckhoven C; Funke H
    Neurosci Lett; 1998 Jan; 240(1):1-4. PubMed ID: 9488160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel MPZ gene mutation in exon 2 causing late-onset demyelinating Charcot-Marie-Tooth disease.
    Chavada G; Rao DG; Martindale J; Hadjivassiliou M
    J Clin Neuromuscul Dis; 2012 Jun; 13(4):206-8. PubMed ID: 22622165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination.
    Warner LE; Hilz MJ; Appel SH; Killian JM; Kolodry EH; Karpati G; Carpenter S; Watters GV; Wheeler C; Witt D; Bodell A; Nelis E; Van Broeckhoven C; Lupski JR
    Neuron; 1996 Sep; 17(3):451-60. PubMed ID: 8816708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and in silico evidence for and against pathogenicity of 11 new mutations in the MPZ gene.
    Brozková D; Mazanec R; Haberlová J; Sakmaryová I; Seeman P
    Clin Genet; 2010 Jul; 78(1):81-7. PubMed ID: 20456450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.